• News
  • SAN DIEGO
  • BioTech

Mirati Therapeutics receives orphan drug designation for mocetinostat

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Mirati Therapeutics Inc.

9393 Towne Centre Dr. Ste., 200
San Diego, CA 92121

Mirati Therapeutics Inc. Executive(s):

Charles Baum, MD, PhD.

  • Chief Executive Officer, President
Subscribe Today!